ES2174863T3 - PIRIMIDINE COMPOUNDS AND ITS USE AS PHARMACEUTICAL COMPOUNDS. - Google Patents
PIRIMIDINE COMPOUNDS AND ITS USE AS PHARMACEUTICAL COMPOUNDS.Info
- Publication number
- ES2174863T3 ES2174863T3 ES94304104T ES94304104T ES2174863T3 ES 2174863 T3 ES2174863 T3 ES 2174863T3 ES 94304104 T ES94304104 T ES 94304104T ES 94304104 T ES94304104 T ES 94304104T ES 2174863 T3 ES2174863 T3 ES 2174863T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- formula
- pirimidine
- pharmaceutical
- pyramidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 5
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
SE PRESENTAN COMPUESTOS FARMACEUTICOS QUE SON COMPUESTOS DE PIRIMIDINA FUNDIDA EN AZOLO QUE TIENEN LA FORMULA I EN LA CUAL A-B JUNTO CON EL ANILLO DE PIRIMIDINA FORMA (A) UNA PIRAZOLO [1,5A]PIRAMIDINA DE LA FORMULA (A), (B) UNA [1,2,4]TRIAZOLO[1,5A]PIRIMIDINA DE LA FORMULA (B); (C) UNA IMIDAZO[1,5-A]PIRAMIDINA DE LA FORMULA (C); O (D) UNA IMIDAZO[1,2-A]PIRAMIDINA DE LA FORMULA (D).PHARMACEUTICAL COMPOUNDS ARE PRESENTED WHICH ARE PIRIMIDINE COMPOUNDS FOUNDED IN AZOLO THAT HAVE FORMULA I IN WHICH AB NEXT TO THE PYRIMIDINE RING SHAPE (A) A PIRAZOLO [1,5A] PYRAMIDINE OF FORMULA (A), (B) ONE [1,2,4] TRIAZOL [1,5A] PYRIMIDINE OF THE FORMULA (B); (C) AN IMIDAZO [1,5-A] FORMULA PYRAMIDINE (C); OR (D) AN IMIDAZO [1,2-A] FORMULA PYRAMIDINE (D).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93304513 | 1993-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2174863T3 true ES2174863T3 (en) | 2002-11-16 |
Family
ID=8214429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94304104T Expired - Lifetime ES2174863T3 (en) | 1993-06-10 | 1994-06-07 | PIRIMIDINE COMPOUNDS AND ITS USE AS PHARMACEUTICAL COMPOUNDS. |
Country Status (5)
Country | Link |
---|---|
US (3) | US5571813A (en) |
JP (1) | JPH072860A (en) |
CA (1) | CA2125458A1 (en) |
DE (1) | DE69430279T2 (en) |
ES (1) | ES2174863T3 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0714898B1 (en) * | 1994-06-21 | 2001-11-14 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE |
US6664261B2 (en) | 1996-02-07 | 2003-12-16 | Neurocrine Biosciences, Inc. | Pyrazolopyrimidines as CRF receptor antagonists |
EA003587B1 (en) * | 1996-04-04 | 2003-06-26 | Баниу Фармасьютикал Ко., Лтд. | Method of preventing and/or treating heart failure and dysfunction with endothelin antagonists |
AU757071B2 (en) * | 1996-04-04 | 2003-01-30 | Msd K.K. | Method of treating heart failure with endothelin antagonists |
US6194410B1 (en) * | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
US6277857B1 (en) * | 1998-09-25 | 2001-08-21 | American Cyanamid Company | Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines |
CA2465326C (en) | 2001-11-01 | 2011-03-29 | Icagen, Inc. | Pyrazolopyrimidines for decreasing ion flow through a voltage-dependent sodium channel |
US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
US7119200B2 (en) * | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
NZ539163A (en) | 2002-09-04 | 2007-03-30 | Schering Corp | Pyrazolo[1,5-a]pyrimidine compounds useful as cyclin dependent kinase (CDK) inhibitors |
TWI344468B (en) | 2002-09-04 | 2011-07-01 | Schering Corp | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7196078B2 (en) * | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
CN1701074A (en) * | 2002-09-04 | 2005-11-23 | 先灵公司 | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US8580782B2 (en) * | 2002-09-04 | 2013-11-12 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
US7205308B2 (en) * | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7161003B1 (en) | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
ES2285164T3 (en) * | 2002-09-04 | 2007-11-16 | Schering Corporation | PIRAZOLOPIRIMIDINAS AS INHIBITORS OF CYCLINE-DEPENDENT KINASES. |
ATE362474T1 (en) * | 2002-09-04 | 2007-06-15 | Schering Corp | PYRAZOLO(1,5-A)PYRIMIDINES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES |
GB0302094D0 (en) * | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
US7329658B2 (en) * | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
EP1599482A4 (en) * | 2003-02-28 | 2008-10-01 | Teijin Pharma Ltd | Pyrazolo 1,5-a pyrimidine derivatives |
JP2006213598A (en) * | 2003-03-19 | 2006-08-17 | Sanwa Kagaku Kenkyusho Co Ltd | Pyrazolopyrimidine compound and use of the same |
WO2004087707A1 (en) * | 2003-03-31 | 2004-10-14 | Vernalis (Cambridge) Limited | Pyrazolopyrimidine compounds and their use in medicine |
WO2004089471A2 (en) * | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
EP1782859A3 (en) * | 2003-04-11 | 2009-09-30 | High Point Pharmaceuticals, LLC | Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines |
US20070275961A1 (en) * | 2003-06-04 | 2007-11-29 | Vernalis (Cambridge) Limited. | Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine |
US6949895B2 (en) * | 2003-09-03 | 2005-09-27 | Axcelis Technologies, Inc. | Unipolar electrostatic quadrupole lens and switching methods for charged beam transport |
GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
WO2006040329A1 (en) * | 2004-10-12 | 2006-04-20 | Novo Nordisk A/S | 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
WO2006068954A2 (en) * | 2004-12-21 | 2006-06-29 | Schering Corporation | PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS |
JP2009507843A (en) * | 2005-09-09 | 2009-02-26 | シェーリング コーポレイション | Aza-fused cyclin-dependent kinase inhibitors |
AR056206A1 (en) | 2005-10-06 | 2007-09-26 | Schering Corp | PIRAZOLPIRIMIDINAS AS INHIBITORS OF PROTEIN KINASES |
JP2007119352A (en) * | 2005-10-25 | 2007-05-17 | Ube Ind Ltd | Method for producing 2-aryl- or heteroarylacetic acid compound |
CA2627306A1 (en) * | 2005-11-01 | 2007-05-10 | Transtech Pharma, Inc. | Pharmaceutical use of substituted amides |
CA2627307A1 (en) * | 2005-11-01 | 2007-05-10 | Transtech Pharma, Inc. | Pharmaceutical use of substituted amides |
JP2009530346A (en) * | 2006-03-21 | 2009-08-27 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | Adamantane derivatives for the treatment of metabolic syndrome |
BRPI0710669A2 (en) | 2006-04-07 | 2011-08-16 | High Point Pharmaceuticals Llc | 11b-hydroxysteroid dehydrogenase type 1 active compounds |
WO2007144394A2 (en) * | 2006-06-16 | 2007-12-21 | High Point Pharmaceuticals, Llc. | Pharmaceutical use of substituted piperidine carboxamides |
WO2008006702A1 (en) * | 2006-07-13 | 2008-01-17 | High Point Pharmaceuticals, Llc. | 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
EP1878721A1 (en) * | 2006-07-13 | 2008-01-16 | Novo Nordisk A/S | 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
WO2008101886A1 (en) * | 2007-02-23 | 2008-08-28 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
JP2010519239A (en) * | 2007-02-23 | 2010-06-03 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | N-admantylbenzamide as an inhibitor of 11-beta-hydroxysteroid dehydrogenase |
WO2008101914A2 (en) | 2007-02-23 | 2008-08-28 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
JP2010519242A (en) * | 2007-02-23 | 2010-06-03 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | New compounds |
CA2679866A1 (en) * | 2007-03-09 | 2008-09-18 | High Point Pharmaceuticals, Llc | Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
JP2010522766A (en) * | 2007-03-28 | 2010-07-08 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | 11 beta-HSD1 active compound |
ES2399912T3 (en) * | 2007-04-11 | 2013-04-04 | High Point Pharmaceuticals, Llc | New compounds |
CN101711106B (en) * | 2007-04-24 | 2013-02-06 | 高点制药有限责任公司 | Pharmaceutical use of substituted amides |
EP2433496A1 (en) | 2007-05-08 | 2012-03-28 | Burnham Institute for Medical Research | Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification |
WO2009039323A1 (en) * | 2007-09-19 | 2009-03-26 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
WO2009039322A1 (en) * | 2007-09-19 | 2009-03-26 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
WO2009039321A1 (en) * | 2007-09-19 | 2009-03-26 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
NZ604018A (en) | 2010-06-07 | 2015-02-27 | Novomedix Llc | Furanyl compounds and the use thereof |
CN103930422A (en) | 2011-07-19 | 2014-07-16 | 无限药品股份有限公司 | Heterocyclic compounds and uses thereof |
US9163027B2 (en) | 2012-11-21 | 2015-10-20 | Stategics, Inc. | Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival |
ES2702951T3 (en) | 2014-04-04 | 2019-03-06 | Syros Pharmaceuticals Inc | Inhibitors of cyclin-dependent kinases 7 (cdk7) |
WO2015154022A1 (en) * | 2014-04-05 | 2015-10-08 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2448542A1 (en) * | 1979-02-06 | 1980-09-05 | Landerlan Sa Lab | 7-Amino 1,2,4-triazolo 2,3-A pyrimidine(s) - are coronary vasodilators, hypoglycemics and anaphylaxis inhibitors |
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them |
PT94960A (en) * | 1989-08-11 | 1991-04-18 | Ici Plc | PROCESS FOR THE PREPARATION OF QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US5100897A (en) * | 1989-08-28 | 1992-03-31 | Merck & Co., Inc. | Substituted pyrimidinones as angiotensin ii antagonists |
CA2057089A1 (en) * | 1990-12-07 | 1992-06-08 | Eric E. Allen | Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
HU208693B (en) * | 1991-02-22 | 1993-12-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them |
US5202328A (en) * | 1991-03-06 | 1993-04-13 | Merck & Co., Inc. | Substituted fused pyrimidinones |
US5187179A (en) * | 1991-03-22 | 1993-02-16 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole |
US5358950A (en) * | 1991-07-05 | 1994-10-25 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists |
TW300219B (en) * | 1991-09-14 | 1997-03-11 | Hoechst Ag | |
FR2687677B1 (en) * | 1992-02-24 | 1996-10-11 | Union Pharma Scient Appl | NOVEL ANGIOTENSIN II RECEPTOR ANTAGONIST POLYAZAINDENES DERIVATIVES; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
WO1993017681A1 (en) * | 1992-03-02 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
WO1993018035A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
WO1993017682A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
-
1994
- 1994-06-06 US US08/254,803 patent/US5571813A/en not_active Expired - Fee Related
- 1994-06-07 ES ES94304104T patent/ES2174863T3/en not_active Expired - Lifetime
- 1994-06-07 DE DE69430279T patent/DE69430279T2/en not_active Expired - Fee Related
- 1994-06-08 CA CA002125458A patent/CA2125458A1/en not_active Abandoned
- 1994-06-09 JP JP6127441A patent/JPH072860A/en active Pending
-
1995
- 1995-05-26 US US08/451,586 patent/US5602136A/en not_active Expired - Fee Related
- 1995-05-26 US US08/451,799 patent/US5602137A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH072860A (en) | 1995-01-06 |
CA2125458A1 (en) | 1994-12-11 |
US5602137A (en) | 1997-02-11 |
DE69430279T2 (en) | 2003-03-06 |
US5571813A (en) | 1996-11-05 |
DE69430279D1 (en) | 2002-05-08 |
US5602136A (en) | 1997-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2174863T3 (en) | PIRIMIDINE COMPOUNDS AND ITS USE AS PHARMACEUTICAL COMPOUNDS. | |
ATE307815T1 (en) | SUBSTITUTED 2-PYRIMIDINYL-6,7,8,9- TETRAHYDROPYRIMIDO(1,2-A)PYRIMIDINE-4-ONE- AND 7-PYRIMIDINYL-2,3-DIHYDROIMIDAZO(1,2-A)PYRIMIDINE- 5(1H) ONDERIVATES AGAINST NEURODEGENERATIVE DISEASES | |
GT199900070A (en) | DERIVATIVES OF ISOTIAZOLE, USEFUL AS ANTI-CANCER AGENTS. | |
MX9202838A (en) | IMIDAZO [1,5-A] QUINOXALINAS. | |
ES2118835T3 (en) | 2-ETHYL-1H-IMIDAZO (4,5-C) QUINOLIN-4-AMINAS ANTIVIRICAS. | |
NO20021356D0 (en) | Alkylenediamine-substituted pyrazolo [1,5, -a] -1,5-pyrimidines and pyrazolo [1,5-a] -1,3,5-triazines | |
TR200400746T4 (en) | N- (5,7-dimethoxy [1,2,4] triazolo [1,5-a] pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides | |
DK0708772T3 (en) | Imidazo [4,5-c] pyridin-4-amines | |
DK1699795T3 (en) | Substituted 8'-pyrid (ml) dinyldihydrospiro [cycloalkylamine] pyrimido [1,2-a] pyrimidine-6-derivatives | |
BR0108715A (en) | 1,5-disubstituted 3,4-dihydro-1h-pyrimido [4,5-d] -pyrimidin-2-one compounds and their use in the treatment of csbp / p38 kinase mediated diseases | |
WO2000012504A3 (en) | Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one | |
ES2170259T3 (en) | EMPLOYMENT OF LIPIDS AS AUXILIARY AGENTS IN OBTAINING SOLID PHARMACEUTICAL FORMS ACCORDING TO THE FUSION EXTRUSION PROCEDURE. | |
ECSP055823A (en) | DERIVATIVES OF [6,7-DIHIDRO-5H-IMIDAZO [1,2-a] IMIDAZOL-3-SULPHONYLAMINE] -PROPIONAMIDE | |
TR200000152T2 (en) | New compounds. | |
ATE24510T1 (en) | IMIDAZO(1,2-C)PYRAZOLO(3,4-E)PYRIMIDINES AND THEIR PRODUCTION. | |
CA2153775A1 (en) | Potentiation of Temozolomide in Human Tumour Cells | |
EE200100377A (en) | Use of Imidazo [1,5-a] -pyrido [3,2-e] -pyrazinones as Medicines | |
DK0837860T3 (en) | Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-c] -1,2,4-triazolo [4,3-alpha] pyridines | |
ES2196824T3 (en) | DERIVED FROM REPLACED TRIAZOLO-PIRIDAZINA AND PHARMACEUTICAL COMPOSITIONS MANUFACTURED WITH THE SAME. | |
ES2140648T3 (en) | COMPOUNDS OF 5-ALCOXI (1,2,4) TRIAZOL (1,5-C) PIRIMIDIN-2 (3H) -TIONA AND ITS USE IN THE PREPARATION OF 2,2'-DITIOBIS (5-ALCOXI (1,2, 4) TRIAZOL (1,5-C) PIRIMIDINA) AND 2-CHLOROSULFONIL-5-ALCOXI (1,2,4) TRIAZOL (1,5-C) PIRIMIDINA. | |
ITMI991740A0 (en) | DERIVATIVES OF 1H-PYRIDO 3,4-B INDOL-1-ONE | |
HRP20050790A2 (en) | New combinations and new use of selected pharmaceutically active compounds | |
IT8820680A0 (en) | BENZAZEPINE DERIVATIVES VASODILATORY ADAPTIVITY. | |
ITMI991741A0 (en) | DERIVATIVES OF 1,2-DIHYDRO-1-OXO-PYRAZINE 1,2-A INDEL | |
DK381989D0 (en) | LABELED BENZODIAZEPINER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 628559 Country of ref document: ES |